Insider Transactions in Q1 2022 at Collegium Pharmaceutical, Inc (COLL)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2022
|
Shirley R. Kuhlmann EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
734
-0.49%
|
$13,212
$18.99 P/Share
|
|
Mar 01
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
76,094
-9.76%
|
$1,369,692
$18.71 P/Share
|
|
Feb 18
2022
|
Scott Dreyer EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,559
-8.01%
|
$221,739
$21.61 P/Share
|
|
Feb 10
2022
|
Scott Dreyer EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,659
-3.81%
|
$181,203
$17.63 P/Share
|
|
Feb 10
2022
|
Scott Dreyer EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,175
+18.86%
|
-
|
|
Feb 10
2022
|
Shirley R. Kuhlmann EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,179
-3.55%
|
$190,043
$17.63 P/Share
|
|
Feb 10
2022
|
Shirley R. Kuhlmann EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
71,041
+18.1%
|
-
|
|
Feb 10
2022
|
Joseph Ciaffoni President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
52,997
-6.02%
|
$900,949
$17.63 P/Share
|
|
Feb 10
2022
|
Joseph Ciaffoni President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
190,034
+18.43%
|
-
|
|
Feb 10
2022
|
Colleen Tupper EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,058
-2.23%
|
$68,986
$17.63 P/Share
|
|
Feb 10
2022
|
Colleen Tupper EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,712
+19.3%
|
-
|
|
Feb 10
2022
|
Richard Malamut EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,300
-2.33%
|
$107,100
$17.63 P/Share
|
|
Feb 10
2022
|
Richard Malamut EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,006
+13.19%
|
-
|
|
Jan 10
2022
|
Scott Dreyer EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-0.91%
|
$13,319
$19.05 P/Share
|
|
Jan 03
2022
|
Joseph Ciaffoni President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,090
-0.41%
|
$19,620
$18.68 P/Share
|